Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors.

Bioorg Med Chem Lett

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, United States.

Published: April 2010

A series of tetrahydropyrido-pyrazole cathepsin S (CatS) inhibitors with thioether acetamide functional groups were prepared with the goal of improving upon the cellular activity of amidoethylthioethers. This Letter describes altered amide connectivity, in conjunction with changes to other binding elements, resulting in improved potency, as well as increased knowledge of the relationship between this chemotype and human CatS activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.01.103DOI Listing

Publication Analysis

Top Keywords

binding elements
8
tetrahydropyrido-pyrazole cathepsin
8
thioether acetamides
4
acetamides binding
4
elements tetrahydropyrido-pyrazole
4
cathepsin inhibitors
4
inhibitors series
4
series tetrahydropyrido-pyrazole
4
cathepsin cats
4
cats inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!